Skip to main content

Table 2 Cannabis use characteristics amongst patients reporting past-month cannabis use (n = 1178)

From: The association between cannabis use and outcome in pharmacological treatment for opioid use disorder

Cannabis use characteristic

Statistic

Daily use; n (%)

798 (67.7%)

Age of first cannabis use in years; mean (SD)

14.2 (4.5)

Age at first regular cannabis use in years (defined as use at least twice monthly); mean (SD)

16.7 (6.9)

Self-reported cannabis side effects; n (%)

583 (49.5%)

Type of side effects reported amongst individuals reporting cannabis-related side effectsa; n (%)

 

 Sexual problems

2 (0.3%)

 Weight gain

28 (4.8%)

 Paranoia

62 (10.6%)

 Hallucinations

10 (1.7%)

 Lack of motivation

101 (17.3%)

 Slower thought process

153 (26.2%)

 Decreased school/work performance

86 (14.8%)

 Other

141 (24.2%)

 Marijuana cravings score; mean (SD)

37.4 (16.3)

Self-reported impact of cannabis on MAT

 

 No impact

881 (74.9%)

 Helps with opioid cravings

81 (6.9%)

 Helps with opioid withdrawal symptoms

98 (8.3%)

 Helps with MAT dose

14 (1.2%)

 Helps with pain management

17 (1.4%)

 Increases effect of MAT

31 (2.6%)

 Other positive effects

82 (7%)

 Worsens OUD symptoms

28 (2.4%)

 Unsure

15 (1.3%)

  1. SD standard deviation, MAT medication-assisted treatment, OUD opioid use disorder
  2. aParticipants were able to report only one primary side effect experienced